-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster III

Symposia: Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Paula Acuña1*, Elena Monzón Manzano, PhD1*, María Teresa Alvarez-Román, PhD, MD1,2*, Elena G Arias-Salgado, PhD1*, Eduardo Garcia Perez1*, Monica Martin Salces, PhD, MD1*, Maria Isabel Rivas Pollmar, PhD, MD1*, Rick Kapur, MD, PhD3,4, Victor Jimenez Yuste, MD, PhD1,2* and Nora Butta, PhD1*

1Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
2Faculty of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
3Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands
4Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Angela C Weyand, MD1, Michelle Sholzberg, MDCM, MSc2, Jacob S Lai, PhD3*, Benjamin Kim, MD, MPhil3, Adam Rosenthal, PhD3*, Scott M Robertson3*, Gary Patou, MD3* and Robert F. Sidonio, Jr., MD, MSc4

1Department of Pediatrics and Communicable Diseases, Division of Pediatric Hematology and Oncology, University of Michigan, Ann Arbor, MI
2Hematology-Oncology Clinical Research Group, Division of Hematology, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada
3Star Therapeutics, Inc., South San Francisco, CA
4Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA

Hu Yingying1,2*, Xuan Zhou3*, Shuhua Li, MD4*, Jing Sun5*, Jieyu Ye, PhD6*, Qifa Liu, MD7,8,9,10 and Houmei Feng11*

1Southmedical University Nanfang hospital, Guangzhou, AL, China
2Southmedical University Nanfang hospital, guangzhou, China
3Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
4Southern medical university, guangzhou, China
5Nanfang Hospital Southern Medical University, Guangzhou, China
6Nanfang Hospital,Southern Medical University, Guangzhou, CHN
7Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China
8Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
9Department of Hematology, Nanfang Hospital, Southern medical university CN, Guangzhou, China
10Nanfang Hospital, Southern Medical University, Guangzhou, China
11Southmedical Univeisity Nanfang hospital, guangzhou, China

Michelle Sholzberg, MDCM, MSc1, Angela C Weyand, MD2, Jacob S Lai, PhD3*, Benjamin Kim, MD, MPhil3, Gary Patou, MD3*, Nicole M. Engel-Nitz, PhD, MS4*, Qiana Amos, PhD, MPH4* and Robert F. Sidonio, Jr., MD, MSc5

1Hematology-Oncology Clinical Research Group, Division of Hematology, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada
2Department of Pediatrics and Communicable Diseases, Division of Pediatric Hematology and Oncology, University of Michigan, Ann Arbor, MI
3Star Therapeutics, Inc., South San Francisco, CA
4HEOR, Optum, Eden Prairie, MN
5Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA

Carolyn M Millar, MD, PhD1,2*, Priyanka Raheja, MBBS, MD3*, Allison P Wheeler, MD/MSCI4, Shrinath Kshirsagar, MD, MBBS5*, Christian Schoergenhofer, MD, PhD6*, Nicoletta C Machin, DO7,8, Cihan Ay9*, Almudena Tercero, PharmD10*, Hayley Lane10*, Christopher J Horvath, DVM, MS10*, Sandip Panicker, PhD10, Gary Patou, MD10*, Benjamin Kim, MD, MPhil10 and Savita Rangarajan, MD11,12

1Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
2Imperial College Healthcare NHS Trust, London, United Kingdom
3The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, United Kingdom
4Washington Center for Bleeding Disorders, Division of Pediatric Hematology/Oncology & Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA
5Advanced Center for Research in Oncology, Hematology and Rare Disorders (ACOHRD), K J Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India
6Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
7Hemophilia Center of Western Pennsylvania, Pittsburgh, PA
8Division of Classical Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
9Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
10Star Therapeutics, Inc., South San Francisco, CA
11University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
12Hematology Laboratory, K J Somaiya Hospital and Research Centre, Mumbai, India

Shruti Vilas Kharat, MSc1*, Nayaab Khan, PhD2*, Alina He2*, Chris Foo, PharmD2*, Kranti Patil, B.Sc3*, Gurpreetkaur Saini, M.Sc3*, Shreyas Tawde, M.Sc3*, Benjamin Kim, MD, MPhil2, Savita Rangarajan, MD3 and Shrimati Shetty, PhD3*

1Hematology Laboratory, K J Somaiya Hospital and Research Centre, Mumbai, AL, India
2Star Therapeutics, Inc., South San Francisco, CA
3Hematology Laboratory, K J Somaiya Hospital and Research Centre, Mumbai, India

Drake Kienzle, BA1*, Eliakim Munda, BS2*, Constantine Daskalakis, ScD3* and Ruben Rhoades, MD, MS2

1Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
2Division of Hematology, Department of Medicine, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA
3Division of Biostatistics & Bioinformatics, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA

Miriam Moser, MD1*, Cihan Ay2,3*, Christian Schoergenhofer, MD, PhD4*, James C Gilbert, MD5*, Shuhao Zhu, PhD6* and Bernd Jilma, MD7

1Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
2Division of Hematology, Medical University of Vienna, Vienna, Austria
3Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
4Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
5Band Therapeutics, LLC, Lexington, MA
6Band Therapeutics LLC, a Guardian Therapeutics company., Lexington, MA
7Department of Clinical Pharmacology, Medical University of Vienna, Wien, Austria

*signifies non-member of ASH